Scholar Rock Holding Corporation (SRRK)
收市後：
| 前收市價 | 14.69 |
| 開市 | 14.10 |
| 買盤 | 14.44 x 100 |
| 賣出價 | 14.61 x 100 |
| 今日波幅 | 13.94 - 14.82 |
| 52 週波幅 | 5.56 - 21.17 |
| 成交量 | |
| 平均成交量 | 837,816 |
| 市值 | 1.156B |
| Beta 值 (5 年，每月) | 0.89 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.99 |
| 業績公佈日 | 2024年8月07日 - 2024年8月12日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 26.25 |
InvestorPlace3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
Investors continue to search for the next big weight loss drug stocks following the success of Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO). So-called GLP-1 receptor agonists represent a fundamental change in weight loss treatment. The active ingredients produce substantially greater weight loss than any other drugs on the market. I’d venture a guess that some investors assume that the best returns have already been had. However, there’s lots of evidence suggesting otherwise. Global obesity
Insider MonkeyBillionaire Paul Tudor Jones and Insiders Love These 10 Stocks
In this article, we will take a detailed look at Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Paul Tudor Jones and Insiders Love These 5 Stocks. In an interview given to the Palm Beach Civic Association in January 2024, billionaire Paul Tudor Jones said that […]
InvestorPlace3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
Americans live longer than ever, and a handful of biotech stocks stand at the forefront of longevity’s future. Many misconceive anti-aging stocks as peddling some magic pill that inexplicably makes you live longer — that perception is pure fiction. While many treatments help extend your life if leveraged properly and consistently — namely, diet and exercise — the most compelling longevity stocks address specific age-associated ailments instead. As we age, rapid neurological and physical degenera
